Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Orion Group Holdings, Inc.NYSE: ORN
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of $190.42M rose 15.0% year over year, ahead of the +6.3% change in trailing-twelve-month cost of revenue. Sequentially, it fell 7.6% from the prior quarter. Over 3 fiscal years it compounded at +2.3% a year.
Context
- Cost of revenue amounted to 87.6% of revenue in FY2025, down 0.9 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +15.0% holds above the trailing-twelve-month pace of +6.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 746.65M USD
- Year-over-year change
- +5.9%
- 4-year CAGR
- +7.4%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 746.65M | +5.9% |
| FY2024 | 2024-12-31 | 705.23M | +8.5% |
| FY2023 | 2023-12-31 | 650.12M | -6.8% |
| FY2022 | 2022-12-31 | 697.58M | +24.5% |
| FY2021 | 2021-12-31 | 560.39M | — |
Cost of Revenue vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +6.3% is the 6th highest of 10, against a peer median of +10.2%.
- Cost of revenue amounts to 87.7% of revenue for ORN, versus a peer median of 69.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $1.39B USD | -6.4% | -5.7% | 89.9% | |
| LTM Mar 2026 | $792.89M USD | +13.5% | +1.0% | 93.8% | |
| LTM Mar 2026 | $771.43M USD | +6.3% | +2.3% | 87.7% | |
| LTM Apr 2026 | $382.74M USD | +10.2% | +5.6% | 73.1% | |
| LTM Feb 2026 | $271.99M USD | -1.9% | -3.3% | 69.3% | |
| LTM Apr 2026 | $252.9M USD | +3.9% | +0.6% | 61.7% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $202.09M USD | +6.0% | +8.6% | 79.5% |
| LTM Mar 2026 | $50.63M USD | +14.1% | +10.4% | 69.1% | |
| LTM Feb 2026 | $48.03M USD | +32.6% | +28.9% | 39.7% | |
| LTM Mar 2026 | £15.22M GBP | — | -10.7% | — | |
| LTM Mar 2026 | $6.4M USD | +5463.5% | -27.6% | 34.5% | |
| Peer median (excluding ORN) | — | +10.2% | +0.8% | 69.3% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 601.36M | 748.32M | 711.78M | 796.39M | 852.26M |
| Cost of Revenue | 560.39M | 697.58M | 650.12M | 705.23M | 746.65M |
| Gross Profit | 40.97M | 50.74M | 61.66M | 91.16M | 105.61M |
| Gross Margin | 6.8% | 6.8% | 8.7% | 11.4% | 12.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 60.18M | 62.5M | 69.43M | 82.54M | 93.47M |
| Operating Expenses | 50.28M | 58.77M | 68.29M | 79.64M | 93.47M |
| Depreciation & Amortization | 25.43M | 24.06M | 23.88M | 22.77M | 30.52M |
| EBITDA | 4.7M | 11.06M | 15.68M | 31.39M | 42.29M |
| EBITDA Margin | 0.8% | 1.5% | 2.2% | 3.9% | 5.0% |
| Operating Income | (9.32M) | (8.03M) | (6.63M) | 11.52M | 12.14M |
| Operating Margin | -1.5% | -1.1% | -0.9% | 1.4% | 1.4% |
| Interest Income | 136K | 104K | 103K | 207K | 0 |
| Interest Expense | 5.08M | 4.46M | 11.66M | 13.38M | 8.56M |
| Other Income / Expenses | (4.74M) | (4.15M) | (10.92M) | (12.82M) | (9.24M) |
| Income Before Tax | (14.06M) | (12.18M) | (17.55M) | (1.3M) | 2.91M |
| Pre-Tax Margin | -2.3% | -1.6% | -2.5% | -0.2% | 0.3% |
| Income Tax Expense | 502K | 429K | 330K | 348K | 419K |
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Net Margin | -2.4% | -1.7% | -2.5% | -0.2% | 0.3% |
| EPS (Basic) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| EPS (Diluted) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| Weighted Avg Shares | 30.76M | 31.4M | 32.35M | 34.78M | 39.63M |
| Weighted Avg Shares (Diluted) | 30.76M | 31.4M | 32.35M | 34.78M | 39.64M |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.